Abstract
With the tremendously increasing numbers of novel drug candidates, there remains a compelling need for rapid screening methods for drug-like physiochemical and pharmacokinetic properties. Different technologies have emerged that enable rapid screening in vitro for sorting out new chemical entity (NCE) classes. It is invaluable for these technologies being developed early in the drug discovery process to avoid the loss of cost and time in late development due to poor absorption and/or bioavailability. In this study, liposome electrokinetic chromatography (LEKC) serves as a convenient, rapid and cost-effective tool to determine lipophilicity and to predict human oral absorption. Twenty-seven organic neutral molecules were evaluated by octanol/water system (log P ow) and LEKC (log k), and linear solvation energy relationship (LSER) analysis was conducted to compare the retention mechanism between LEKC and octanol/water system. LEKC can provide a rapid indirect measurement of log P ow for small organic neutral molecules. A clearly sigmoidal relationship could be seen by correlating log k with the fraction of 25 drugs absorbed in humans (Fa), and the outliers suggested the involvement of non-transcellular passive diffusion, e.g. active transport, paracellular route; on the contrary, it is not the case with the octanol/water system. Therefore, LEKC, in combination with other permeability prediction model, can provide a primary screen for a large number of drug candidates at early stage of the drug discovery process with high-throughput and at low-cost.
Similar content being viewed by others
References
Leo A, Hansch C, Elkins D (1971) Chem Rev 71:525–394
Waterbeemd H Vd (2003) Drug bioavailability. In: Waterbeemd H Vd, Lennernäs H, Artursson P (eds) Physico-chemical approaches to drug absorption. Wiley, New York, pp 3–20
Fujita T, Iwasa J, Hansch C (1964) J Am Chem Soc 86:5175–5180
Poole SK, Durtham D, Kibbey C (2000) J Chromatogr A 745:117–126
Herbert BJ, Dorsey JG (1995) Anal Chem 67:744–749
Liu XY, Nakamura C, Yang Q, Kamo N, Miyake J (2002) J Chromatogr A 961:113–118
Escuder-Gilabert J, Martínez-Pla JJ, Sagrado S, Villanueva-Camañas RM, Medina-Hernández MJ (2003) J Chromatogr B 797:21–53
Sun J, Deguchi Y, Chen JM, Zhang RH, Morimoto K (2002) Die Pharmazie 57:497–498
Sun J, Deguchi Y, Chen JM, Zhang RH, Morimoto K (2002) Acta Pharmacol Sin 23:430–438
Sun J, Zhang TH, Li J, Mao JJ, He ZG (2006) Chem J Chinese U 27:349–351
Li J, Sun J, Cui SM, He ZG (2006) J Chromatogr A. doi: 10.1016/j.chroma.2006.07.073
Balon K, Riebesehl BU, Müller BW (1999) Pharm Res 16:882–888
Loidl-Stahlhofen A, Hartmann T, Schöttner M, Röhring C, Brodowsky H, Schmitt J, Keldenich J (2001) Pharm Res 18:1782–1788
Balon K, Riebesehl BU, Müller BW (1999) J Pharm Sci 88:802–806
Plemper van Balen G, Martinet CM, Caron G, Bouchard G, Reist M, Carrupt PA, Fruttero R, Gasco A, Testa B (2004) Med Res Rev 24:299–324
Burns ST, Khaledi MG (2002) J Pharm Sci 91:1601–1612
Carrozzino JM, Khaledi MG (2005) J Chromatogr A 1079:307–316
Carrozzino JM, Khaledi MG (2004) Pharm Res 21:2327–2335
Pascoe RJ, Masucci JA, Foley JP (2006) Electrophoresis 27:793–804
Dinelli G, Mallegni R, Vicari A (1997) Electrophoresis 18:214–219
Bailey DJ, Dorsey JG (2001) J Chromatogr A 919:181–194
Ishihama Y, Oda Y, Uchikawa K, Asakawa N (1995) Anal Chem 67:1588–1595
Ishihama Y, Oda Y, Asakawa N (1996) Anal Chem 68:1028–1032
Ishihama Y, Oda Y, Asakawa N (1996) Anal Chem 68:4281–4284
Mrestani Y, Neubert RHH, Krause A (1998) Pharm Res 15:799–801
Gluck SJ, Benkö MH, Hallberg RK, Steele KP (1996) J Chromatogr A 744:141–146
Klotz WL, Schure MR, Foley JP (2001) J Chromatogr A 930:145–154
Hong M, Weekley BS, Grieb SJ, Foley JP (1998) Anal Chem 70:1394–1403
Razak JL, Cutak BJ, Larive CK, Lunte CE (2001) Pharm Res 18:104–111
Klotz WL, Schure MR, Foley JP (2002) J Chromatogr A 962:207–219
Abraham MH (1993) Chem Soc Rev 22:73–83
Abraham MH, Chadha HS, Whiting GS, Mitchell RC (1994) J Pharm Sci 83:1085–1100
Trone MD, Leonard MS, Khaledi MG (2000) Anal Chem 72:1228–1235
Ishihama Y, Oda Y, Uchikawa K, Aaskawa N (1995) Anal Chem 67:1588–1595
Abraham MH, Treiner C, Roses M, Rafols C, Ishihama Y (1996) J Chromatogr A 752:243–249
Yazdanian M, Glynn S, Wright J, Hawi A (1998) Pharm Res 15:1490–1494
Walter E, Janich S, Roessler BJ, Hilfinger JM, Amidon GL (1996) J Pharm Sci 85:1070–1076
Shan P, Jogani V, Bagchi T, Misra A (2006) Biotechnol Prog 22:186–198
Danelian E, Karlén A, Karlsson R, Winiwarter S, Hansson A, Löfås S, Hämäläinen MD (2000) J Med Chem 43:2083–2086
Oprea TI, Gottfries J (1999) J Mol Graph Model 17:261–274
Willmann S, Schmitt W, Keldenich J, Lippert J, Dressman JB (2004) J Chem Med 47:4022–4031
Sun J, He Z, Cheng G, Wang S, Hao X, Zou M (2004) Med Sci Monit 10:RA5–14
Avdeef A (2001) Curr Top Med Chem 1:277–351
Deconinck E, Hancock T, Coomans D, Massart DL, Vander Heyden Y (2005) J Pharm Biomed Anal 39:91–103
Zhao YH, Le J, Abraham MH, Hersey A, Eddershaw PJ, Luscombe CN, Boutina D, Beck G, Sherborne B, Cooper I, Platts JA (2001) J Pharm Sci 90:749–784
Zhao YH, Abraham MH, Le J, Hersey A, Luscombe CN, Beck G, Sherborne B, Cooper I (2002) Pharm Res 19:1446–1457
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, Y., Sun, J., Liu, H. et al. Prediction of Human Drug Absorption Using Liposome Electrokinetic Chromatography. Chroma 65, 173–177 (2007). https://doi.org/10.1365/s10337-006-0140-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-006-0140-3